Discovery and functional characterization of a neomorphic PTEN mutation
Helio A. Costa(Stanford University), Carlos D. Bustamante(Galena Biopharma (United States)), Jeffrey R. Johnson(Gladstone Institutes), Dominik Oliver(Cancer Research UK), Nevan J. Krogan(QB3), Anna Rychkova(Stanford University), Martin L. Sos(German Cancer Research Center), Muh‐Ching Yee(Stanford University), Angeliki Mavrantoni(Philipps University of Marburg), Kevan M. Shokat(Howard Hughes Medical Institute), Christian R. Halaszovich(Philipps University of Marburg), Francisco M. De La Vega(Stanford University), James M. Ford(Palo Alto University), Billy W. Newton(University of California, San Francisco), Michael G. Leitner(Philipps University of Marburg)
Cited by 52
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
Inferring the Joint Demographic History of Multiple Populations from Multidimensional SNP Frequency Data
|PLoS Genetics|2009|2.1k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
Evolutionary and Biomedical Insights from the Rhesus Macaque Genome
|Science|2007|1.4k